Elena Ridloff, Director at Kymera Therapeutics, Inc. (KYMR), sold 3,000 shares at $87.00 ($261K) on 2026-05-11, disclosed to the SEC on 2026-05-11.
Scheduled sale ($261k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SION | SELL | 2025-08-28 | $1.1M | — | Filing → |
| SION | SELL | 2025-08-21 | $1.9M | — | Filing → |
| KYMR | SELL | 2025-06-11 | $225K | — | Filing → |